
Nouri launches Prenatal Health Probiotic at Target
Microbiome health company Nouri has launched a new prenatal probiotic supplement to support the maternal microbiome.

Microbiome health company Nouri has launched a new prenatal probiotic supplement to support the maternal microbiome.

For Diana Morgan, it all started at a CRN conference in 2007 when the What’s Up with Supps founder took the ‘How to Fascinate’ test by Sally Hogshead.

A new study done in rats has found some synthetic phenethylamine analogs found in weight management dietary supplements may have abuse potential.

The Danish ingredients supplier is celebrating a ‘solid’ financial performance for 2021/22, despite a ‘volatile’ macroeconomic and geopolitical climate. We ask CFO Lise Mortensen how the Ukraine-Russia conflict is impacting business.

Seventure Partners, the global microbiome venture capital, has invested 10 million euros in the pioneering Danish microbiome research company Clinical Microbiomics A/S.

Leading international grocer Iceland is jumping on the sports nutrition trend with an exclusive MyProtein partnership, demonstrating how the grocery retail space offers brands access to huge new markets.

New live culture supplements developed by Health & Her for women entering the perimenopause and menopause life stages aim to promote oestrogen metabolism and reduce age-related conditions associated with hormonal imbalance, such as osteoporosis.

Research suggests what you eat impacts how well you sleep. Conversely, the quality of your sleep can influence dietary choices. FoodNavigator examines this complex relationship and probes the connection between sleep, diet, and health.

Plant-based brands in China aiming to be listed in mainstream supermarkets and convenience stores are still having to educate retailers about the category, as well as extol the virtues of their own products.

Australia’s Therapeutic Goods Administration (TGA) has proposed changes to the scheduling of melatonin and green tea extract, with new dosage indications for the former and a completely new entry into the Poisons Standard for the latter.

A new human clinical trial from South Korea has shown that the supplementation of a probiotic formulation containing two Limosilactobacillus strains for 12 weeks could significantly reduce body fat mass and percentage.